ADHD:
Indications for RITALIN:
Attention deficit hyperactivity disorder.
Adult:
Give in 2–3 divided doses preferably 30–45mins before meals. Usual dose: 20–30mg/day. Max 60mg/day.
Children:
<6yrs: not established. ≥6yrs: initially 5mg twice daily before breakfast and lunch. May increase by 5–10mg weekly; max 60mg/day.
Contraindications:
During or within 14 days of MAOIs.
Boxed Warning:
Abuse and dependence.
Warnings/Precautions:
High potential for abuse and dependence: monitor. Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating. Avoid in known structural cardiac abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease, and other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder. Screen for risk factors of developing a manic episode prior to initiation. Consider discontinuing if new psychotic/manic symptoms occur. Peripheral vasculopathy, including Raynaud's Phenomenon; monitor for digital changes. Monitor growth (esp. children), BP, HR. Reduce dose or discontinue if paradoxical aggravation of symptoms occur. Reevaluate periodically. Pregnancy. Nursing mothers: monitor infants.
See Also:
Pharmacologic Class:
CNS stimulant.
Interactions:
See Contraindications. Avoid concomitant use with halogenated anesthetics (eg, halothane), alcohol. May antagonize antihypertensives. Risk of serotonin syndrome with serotonergic drugs.
Adverse Reactions:
Headache, insomnia, abdominal pain, decreased appetite, anorexia, tachycardia, palpitations, anxiety, hyperhidrosis, weight loss, dry mouth, nausea; priapism, hypertension.
How Supplied:
Caps, tabs—100
Pricing for RITALIN
Sleep-wake disorders:
Indications for RITALIN:
Narcolepsy.
Adult:
Give in 2–3 divided doses preferably 30–45mins before meals. Usual dose: 20–30mg/day. Max 60mg/day.
Children:
<6yrs: not established. ≥6yrs: initially 5mg twice daily before breakfast and lunch. May increase by 5–10mg weekly; max 60mg/day.
Contraindications:
During or within 14 days of MAOIs.
Warnings/Precautions:
Assess risk of abuse prior to initiation; monitor for signs of abuse and dependence while on therapy. Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating. Avoid in known structural cardiac abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease, and other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder; screen for risk before initiation. Consider discontinuing if new psychotic/manic symptoms occur. Peripheral vasculopathy, including Raynaud's Phenomenon; monitor for digital changes. Monitor growth (esp. children), BP, HR. Reduce dose or discontinue if paradoxical aggravation of symptoms occur. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Pharmacologic Class:
CNS stimulant.
Interactions:
See Contraindications. Avoid concomitant use with halogenated anesthetics (eg, halothane), alcohol. May antagonize antihypertensives. Risk of serotonin syndrome with serotonergic drugs.
Adverse Reactions:
Headache, insomnia, abdominal pain, decreased appetite, anorexia, tachycardia, palpitations, anxiety, hyperhidrosis, weight loss, dry mouth, nausea; priapism, hypertension, growth suppression (in children).
How Supplied:
Tabs—100
